NBIX vs QCOM · P/E 45, rev $2.36B vs P/E 16, rev $44.28B
Neurocrine Biosciences Inc (NBIX) versus Qualcomm Incorporated (QCOM) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Not investment advice. Open the NBIX and QCOM stock pages for the full models.
Not investment advice.